AngioDynamics (ANGO) Competitors $8.83 +0.05 (+0.57%) Closing price 04:00 PM EasternExtended Trading$8.83 0.00 (0.00%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. TMO, WST, IART, SRDX, OFIX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Integra LifeSciences (IART), Surmodics (SRDX), Orthofix Medical (OFIX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "medical" sector. AngioDynamics vs. Its Competitors Thermo Fisher Scientific West Pharmaceutical Services Integra LifeSciences Surmodics Orthofix Medical Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment. Is TMO or ANGO more profitable? Thermo Fisher Scientific has a net margin of 15.24% compared to AngioDynamics' net margin of -11.62%. Thermo Fisher Scientific's return on equity of 16.82% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.24% 16.82% 8.38% AngioDynamics -11.62%-3.20%-2.09% Do analysts recommend TMO or ANGO? Thermo Fisher Scientific currently has a consensus price target of $593.00, suggesting a potential upside of 19.09%. AngioDynamics has a consensus price target of $19.00, suggesting a potential upside of 115.18%. Given AngioDynamics' stronger consensus rating and higher possible upside, analysts plainly believe AngioDynamics is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 6 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.73AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, TMO or ANGO? Thermo Fisher Scientific has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Does the media refer more to TMO or ANGO? In the previous week, Thermo Fisher Scientific had 66 more articles in the media than AngioDynamics. MarketBeat recorded 73 mentions for Thermo Fisher Scientific and 7 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.33 beat AngioDynamics' score of 0.75 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 55 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of TMO or ANGO? 89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 5.4% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has preferable earnings & valuation, TMO or ANGO? Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$42.88B4.39$6.34B$17.2928.80AngioDynamics$292.50M1.23-$33.99M-$0.83-10.64 SummaryThermo Fisher Scientific beats AngioDynamics on 12 of the 16 factors compared between the two stocks. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$358.76M$7.10B$5.76B$9.65BDividend YieldN/A1.32%3.91%4.09%P/E Ratio-10.6427.2030.7825.12Price / Sales1.23150.49456.64116.46Price / Cash18.0122.1625.2228.45Price / Book1.964.789.375.95Net Income-$33.99M$178.31M$3.26B$265.46M7 Day Performance-0.11%-0.74%1.88%0.96%1 Month Performance1.61%-1.19%3.73%2.47%1 Year Performance16.18%12.72%28.93%20.24% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics3.9371 of 5 stars$8.83+0.6%$19.00+115.2%+15.4%$358.76M$292.50M-10.64760Analyst UpgradeTMOThermo Fisher Scientific4.929 of 5 stars$462.59+0.4%$593.00+28.2%-19.2%$173.97B$42.88B26.75125,000Trending NewsAnalyst ForecastWSTWest Pharmaceutical Services4.6998 of 5 stars$240.40-0.2%$320.71+33.4%-18.9%$17.33B$2.89B35.9910,600Positive NewsAnalyst RevisionIARTIntegra LifeSciences4.1243 of 5 stars$12.75-1.6%$18.63+46.1%-34.8%$1.01B$1.61B-1.954,396SRDXSurmodics3.832 of 5 stars$38.00+7.3%$43.00+13.2%-7.9%$506.34M$126.08M-30.89450OFIXOrthofix Medical2.5944 of 5 stars$12.94+3.4%$21.50+66.2%-10.1%$490.15M$799.49M-4.081,616ARAYAccuray4.7978 of 5 stars$1.36-2.2%N/A-29.3%$156.57M$446.55M0.001,040News CoverageEarnings ReportAnalyst DowngradeAnalyst RevisionRMTIRockwell Medical4.3252 of 5 stars$0.94-2.0%$4.00+323.7%-59.3%$32.92M$101.49M0.00300Earnings ReportShort Interest ↓RSLSReShape Lifesciences0.0802 of 5 stars$1.88-16.1%N/A-99.7%$5.34M$8.01M-0.0150Positive NewsEarnings ReportStock SplitGap DownABTAbbott Laboratories4.973 of 5 stars$131.38-2.2%$144.47+10.0%+17.4%$233.71B$41.95B16.46114,000Positive NewsISRGIntuitive Surgical4.7112 of 5 stars$471.85+0.4%$595.95+26.3%+0.5%$168.51B$8.35B65.8115,638Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors West Pharmaceutical Services Competitors Integra LifeSciences Competitors Surmodics Competitors Orthofix Medical Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access